Yi Xie
Chief Executive Officer at EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED
Network origin in Yi Xie first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 7 | |
United Gene Holdings Ltd.
1
| Subsidiary | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Yi Xie via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
| INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED | Specialty Stores | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
China General Technology Group Holding Co., Ltd.
 China General Technology Group Holding Co., Ltd. Industrial MachineryProducer Manufacturing China General Technology Group Holding Co Ltd. engages in the operation as a state-owned investment holding company specializing in distribution of industrial equipment and medical devices. It focuses on the development of three core businesses: advanced manufacturing and technical service consulting, medicine and medical health, and trade and engineering contracting. It is divided into eight sub-fields, such as equipment manufacturing, new materials, inspection and certification, medicine, medical, health, engineering contracting, and trade. The company was founded on March 18, 1998 and is headquartered in Beijing, China. | Industrial Machinery | Director/Board Member | |
| Fudan University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
The Chinese Institute of Certified Public Accountants
 The Chinese Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The Chinese Institute of Certified Public Accountants operates as an accounting organization. The private company is based in Beijing, China. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Shanghai Biochip Co., Ltd.
 Shanghai Biochip Co., Ltd. BiotechnologyHealth Technology Shanghai Biochip Co., Ltd. (dba ShanghaiBio Corp.) performs specialty R&D services for global pharma/biotech companies. Situated on its own 10-acre campus in the heart of Shanghai's Zhangjiang Hi-Tech Park, China's Bio/Pharma Valley, ShanghaiBio operates in seven buildings totaling 220,000 SQF that contain offices and laboratories. Its labs provide GLP/GMP-compliant services and continually undergo rigorous internal and external QA audits. The scientific staff is chiefly home-grown talent trained by professionals schooled in western ways. The company was founded in August 2001 and is headquartered in Shanghai, China. | Biotechnology | President | |
| Shanghai Retired Education Workers Association | Corporate Officer/Principal | ||
| Jiangsu Broadcast & Television University | College/University | Undergraduate Degree | |
| The Second Military Medical University | College/University | Graduate Degree | |
| Shanghai Second Medical University | College/University | Doctorate Degree | |
General Technology Group Pharmaceutical Holding Ltd.
 General Technology Group Pharmaceutical Holding Ltd. Financial ConglomeratesFinance General Technology Group Pharmaceutical Holding Ltd. provides pharmaceutical and medical industry investment, asset management, and health consulting services. The company is based in Beijing, China and is ultimately controlled by the Government of China. | Financial Conglomerates | Director/Board Member | |
| School of Life Sciences Fudan University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Longmark Shanghai Healthcare Ltd. | President | ||
Microelectronics Research Center
 Microelectronics Research Center Miscellaneous Commercial ServicesCommercial Services The Microelectronics Research Center is a research and development center located at the University of Texas. The center is based in Austin. The center is focused on education, research, and development in materials and electronic devices, and is funded by the National Science Foundation through the National Nanotechnology Coordinated Infrastructure. The center has recently received a $1 million grant from the W.M. Keck Foundation to create a new data storage and retrieval paradigm centered around synthetic polymers. The center has also reopened its facility for all internal and external users with a cohort module of 40% at any time. | Miscellaneous Commercial Services | Director/Board Member | |
| Shanghai Senior Professor Association | Director/Board Member |
Statistics
International
| China | 14 |
| Hong Kong | 2 |
| United States | 2 |
Sectoral
| Consumer Services | 6 |
| Health Technology | 3 |
| Commercial Services | 3 |
| Retail Trade | 2 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 15 |
| Corporate Officer/Principal | 10 |
| Independent Dir/Board Member | 3 |
| Chairman | 2 |
| President | 2 |
Most connected contacts
| Insiders | |
|---|---|
| Yi Lou | 6 |
| Yu Min Mao | 5 |
| Lin Hu Fang | 5 |
| Yi Guo | 4 |
| Yong Cheng | 3 |
| Song Jin | 2 |
| Hong Wu | 2 |
| Sau Kuen Wong | 1 |
- Stock Market
- Insiders
- Yi Xie
- Company connections
